Pharmacokinetics of nelfinavir and nevirapine in a patient with end-stage renal failure on continuous ambulatory peritoneal dialysis

J Antimicrob Chemother. 2000 May;45(5):716-7. doi: 10.1093/jac/45.5.716.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / pharmacokinetics*
  • Anti-HIV Agents / therapeutic use
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV Infections / metabolism
  • HIV-1
  • Humans
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / metabolism
  • Nelfinavir / pharmacokinetics*
  • Nelfinavir / therapeutic use
  • Nevirapine / pharmacokinetics*
  • Nevirapine / therapeutic use
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Reverse Transcriptase Inhibitors / pharmacokinetics
  • Reverse Transcriptase Inhibitors / therapeutic use

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Nevirapine
  • Nelfinavir